No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DVY Ishares Select Dividend ETF
- 124.900
- +0.520+0.42%
Close May 14 16:00 ET
125.275High124.540Low
125.275High124.540Low260.03KVolume124.840Open124.380Pre Close32.47MTurnover0.17%Turnover Ratio--P/E (Static)151.50MShares125.27552wk High--P/B18.92BFloat Cap100.79452wk Low4.47Dividend TTM151.50MShs Float125.275Historical High3.58%Div YieldTTM0.59%Amplitude15.054Historical Low124.874Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
How Is The Market Feeling About KeyCorp?
KeyCorp's (NYSE:KEY) short percent of float has fallen 26.41% since its last report. The company recently reported that it has 21.05 million shares sold short, which is 2.87% of all regular shares tha
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This growth would be primarily fueled by the expansion of ad
Walmart Remains Least Shorted S&P 500 Consumer Staple Stock in April
CNBC Halftime Report Final Trades: Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals, QUALCOMM
CNBC Halftime Report Final Trades: Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals, QUALCOMM
Truist Finl Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 3.8% Piper Sandler $38 → $41 Maintains Neutral 05/09/2024 11.4% Evercore ISI Group → $44 Reinst
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand "Pfizer for All." The move, reflected in
Comments
'Keep-it-simple'
Handpicking sectors, sheltering in trendy options strategies, going all-in on dividends — none of it has worked as well this year as simply owning the S&P 500.
As 2023 winds down, investors are taking the year’s keep-it-simple lesson to heart.
Amid a 4% rally this month that’s propelled the index’s 2023 advance to 24%, they’ve been pouring money into plain-vanilla stock funds. Equity ETFs have taken in nearly US$...
Handpicking sectors, sheltering in trendy options strategies, going all-in on dividends — none of it has worked as well this year as simply owning the S&P 500.
As 2023 winds down, investors are taking the year’s keep-it-simple lesson to heart.
Amid a 4% rally this month that’s propelled the index’s 2023 advance to 24%, they’ve been pouring money into plain-vanilla stock funds. Equity ETFs have taken in nearly US$...
1
Amid uncertain macroeconomics conditions and market turbulence, investors start turning to dividend stocks with fixed income stream.
And if you're not sure which dividend stock to pick, maybe to purchase dividend exchange-traded funds (ETFs) is a smarter choice.![]()
![]()
Dividend ETFs offer a simple and straightforward solution to getting exposure to stocks that regularly distributing dividends to their shareholders. Investors could take that dividend as inco...
And if you're not sure which dividend stock to pick, maybe to purchase dividend exchange-traded funds (ETFs) is a smarter choice.
Dividend ETFs offer a simple and straightforward solution to getting exposure to stocks that regularly distributing dividends to their shareholders. Investors could take that dividend as inco...
58
11
Read more
broad-minded Bird_75 : n... ..........